National Assembly Vice Chairman Phung Quoc Hien (R) receives Pfizer Group's Regional President for Asia and Emerging Markets Pierre Gaudreault (Source: VNA) Hanoi (VNA) – US-based Pfizer Group, one of the world's premierbiopharmaceutical companies, has signed an agreement on the transfer ofpharmaceutical production technology to Vietnamese enterprises, so firstproducts are scheduled to be produced in 2020.
The information wasmade by the group’s Regional President for Asia and Emerging Markets PierreGaudreault in a meeting with Vietnam’s National Assembly Vice Chairman PhungQuoc Hien in Hanoi on January 10.
Pierre Gaudreaultaffirmed that the signing of the deal shows Pfizer’s commitment to long-terminvestment in Vietnam, thus contributing to the country’s pharmaceuticalindustry and applying technology with international standard in its drugproduction.
According to him, thegroup decided to invest in Vietnam as it sees potential of the Vietnamesemarket and its surrounding areas as well as the country’s open investmentpolicies.
He pledged to sharethe group’s best experiences with Vietnamese enterprises, while hoping that theVietnamese Government will continue creating conditions on policies andprocedures for the group to expand its presence in the country.
NA Vice Chairman PhungQuoc Hien stated that the transfer of technology is a breakthrough in the twosides’ cooperation. This not only is a good chance for Vietnam’s pharmaceuticalproducers to improve their capacity, but also helps Vietnamese people buyhigh-quality drugs at reasonable prices.
He suggested Pfizerstudy Vietnam’s climate to produce types of drugs that are suitable toVietnamese and Southeast Asian markets.
He affirmed thatVietnam will facilitate investment of foreign enterprises, includingPfizer.-VNA
VNA
